Tian DF - Search Results

1

Development of a new high-throughput screening model for human high density lipoprotein receptor (CLA-1) agonists.

Tian DF, Hong B, Si SY. Tian DF, et al. Biomed Environ Sci. 2005 Aug;18(4):265-72. Biomed Environ Sci. 2005. PMID: 16274109

2

Human Adenine Nucleotide Translocase (ANT) Modulators Identified by High-Throughput Screening of Transgenic Yeast.

Zhang Y, Tian D, Matsuyama H, Hamazaki T, Shiratsuchi T, Terada N, Hook DJ, Walters MA, Georg GI, Hawkinson JE. Zhang Y, et al. J Biomol Screen. 2016 Apr;21(4):381-90. doi: 10.1177/1087057115624637. Epub 2016 Jan 8. J Biomol Screen. 2016. PMID: 26746582 Free PMC article.

3

WL-276, an antagonist against Bcl-2 proteins, overcomes drug resistance and suppresses prostate tumor growth.

Wang L, Sloper DT, Addo SN, Tian D, Slaton JW, Xing C. Wang L, et al. Cancer Res. 2008 Jun 1;68(11):4377-83. doi: 10.1158/0008-5472.CAN-07-6590. Cancer Res. 2008. PMID: 18519699 Free PMC article.

4

Structure-activity relationship and molecular mechanisms of ethyl 2-amino-4-(2-ethoxy-2-oxoethyl)-6-phenyl-4h-chromene-3-carboxylate (sha 14-1) and its analogues.

Das SG, Doshi JM, Tian D, Addo SN, Srinivasan B, Hermanson DL, Xing C. Das SG, et al. J Med Chem. 2009 Oct 8;52(19):5937-49. doi: 10.1021/jm9005059. J Med Chem. 2009. PMID: 19743858

5

sHA 14-1, a stable and ROS-free antagonist against anti-apoptotic Bcl-2 proteins, bypasses drug resistances and synergizes cancer therapies in human leukemia cell.

Tian D, Das SG, Doshi JM, Peng J, Lin J, Xing C. Tian D, et al. Cancer Lett. 2008 Feb 8;259(2):198-208. doi: 10.1016/j.canlet.2007.10.012. Epub 2007 Nov 26. Cancer Lett. 2008. PMID: 18037229 Free PMC article.

6

High-throughput screening for growth inhibitors using a yeast model of familial paraganglioma.

Bancos I, Bida JP, Tian D, Bundrick M, John K, Holte MN, Her YF, Evans D, Saenz DT, Poeschla EM, Hook D, Georg G, Maher LJ 3rd. Bancos I, et al. PLoS One. 2013;8(2):e56827. doi: 10.1371/journal.pone.0056827. Epub 2013 Feb 22. PLoS One. 2013. PMID: 23451094 Free PMC article.

7

CD38⁺ B cells affect immunotherapy for allergic rhinitis.

Tian GX, Peng KP, Liu MH, Tian DF, Xie HQ, Wang LW, Guo YY, Zhou S, Mo LH, Yang PC. Tian GX, et al. Among authors: tian df. J Allergy Clin Immunol. 2022 May;149(5):1691-1701.e9. doi: 10.1016/j.jaci.2022.01.012. Epub 2022 Jan 29. J Allergy Clin Immunol. 2022. PMID: 35093485

8

Xinglou Chengqi Decoction improves neurological function in experimental stroke mice as evidenced by gut microbiota analysis and network pharmacology.

Gao Q, Han ZY, Tian DF, Liu GL, Wang ZY, Lin JF, Chang Z, Zhang DD, Xie YZ, Sun YK, Yao XW, Ma DY. Gao Q, et al. Among authors: tian df. Chin J Nat Med. 2021 Dec;19(12):881-899. doi: 10.1016/S1875-5364(21)60079-1. Chin J Nat Med. 2021. PMID: 34961587

9

Tongluo Huatan capsule improves cognitive function by regulating the endocytosis of N-methyl-D-aspartic acid receptors mediated by clathrin in a rat model of vascular dementia.

Gao Q, Tian DF, Zhang DD, Guo YY, Lin JF, Liu GL, Chang Z, Wang YC, Han ZY. Gao Q, et al. Among authors: tian df. J Tradit Chin Med. 2021 Oct;41(5):771-778. doi: 10.19852/j.cnki.jtcm.2021.05.011. J Tradit Chin Med. 2021. PMID: 34708636 Free article.

10

Therapeutic Targets and Mechanism of Xingpi Jieyu Decoction in Depression: A Network Pharmacology Study.

Chang Z, He LJ, Tian DF, Gao Q, Ling JF, Wang YC, Han ZY, Guo RJ. Chang Z, et al. Among authors: tian df. Evid Based Complement Alternat Med. 2021 Jun 23;2021:5516525. doi: 10.1155/2021/5516525. eCollection 2021. Evid Based Complement Alternat Med. 2021. PMID: 34257681 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters